Navigation Links
Presence of fetal cells in women lowers risk of breast cancer but raises risk of colon cancer
Date:5/3/2012

SEATTLE For the first time, scientists have found what could be a causative link between the concentration of circulating Y-chromosome fetal cells in women who gave birth to children of either sex and their risk of later developing breast cancer and colon cancer. The findings show that the presence of fetal cells is a double-edged sword: Women with the lowest concentration of fetal cells were 70 percent less likely to have breast cancer, while women with the highest concentration of fetal cells had a four-fold increased risk for colon cancer when compared with healthy controls.

The how and why of this contradictory role of fetal microchimerism is not known and requires more study, according to Vijayakrishna K. (V.K.) Gadi, M.D., Ph.D, an assistant member of the Clinical Research Division at Fred Hutchinson Cancer Research Center and senior author of a study that appears online in the European Journal of Cancer.

Scientists at the University of Copenhagen, Denmark, led the research, which was based on data from 428 Danish women whose blood was drawn in the mid-1990s when they were cancer free. Ten years later, the cancer status of these women was determined based on an examination of Danish breast and colon cancer registries. Molecular analysis of the blood samples was done at the Hutchinson Center to measure how much microchimerism they had. Male fetal microchimerism was detected in 40 percent of 89 women who had developed breast cancer, and 90 percent of the 67 women who had developed colon cancer. Residual male fetal cells were also found in 70 percent of the 272 women who remained cancer free.

The colon cancer finding was unexpected; no prior studies had ever associated that cancer with fetal microchimerism, Gadi said. The researchers chose to measure microchimerism in women who later developed colon cancer to determine whether the possible beneficial effect of microchimerism is specific to breast cancer, as past studies have shown.

Previous studies, including research by Gadi and colleagues, found associative links between concentrations of fetal microchimerism and a decreased risk of breast cancer as well as a heightened risk of some autoimmune diseases. However, those studies were based on blood drawn from women after the onset of their disease.

"Fetal microchimerism may be highly relevant to later cancer development. However, the study does not allow us to identify the underlying biological mechanisms," Gadi said.

Gadi has a hypothesis (not contained in the study) that the fetal cells could be producing a naturally occurring graft-versus-tumor effect but the effect may be having different impacts based on the cancer type. "There are diseases of the GI tract that are associated with chronic inflammation and it is entirely possible that fetal cells are driving, seeding or initiating that inflammation or are involved in the process," he said regarding the link to colon cancer.

Detection of Y-chromosome fetal cells, thought to originate from previous pregnancies with a male fetus, is common in women. During pregnancy, fetal cells naturally pass into the mother where they can persist in small numbers in the blood and tissues for decades after childbirth.

Interestingly, this latest study also found no obvious association between the number of live-born sons and testing positive for male microchimerism. Overall, 65 percent of women with no live-born sons tested positive for Y-chromosome fetal cells, according to the study.

"A source of Y chromosomes in women with no sons could be unrecognized pregnancies with a male fetus that terminated early," Gadi said regarding a possible explanation.


'/>"/>

Contact: Dean Forbes
dforbes@fhcrc.org
206-667-2896
Fred Hutchinson Cancer Research Center
Source:Eurekalert

Related medicine news :

1. New Allergy Testing Available for Patients Allergic to Penicillin: Determining the Presence of Penicillin Allergy is Essential to Patient Care
2. HD Telepresence Gets More Affordable for SMBs: XVD Espresso HD Delivers Higher Performance at Lower Costs than Traditional Solutions
3. Jackson Surgical Assistants Expands Its National Presence by Merging with Two Atlanta Area Practices
4. ENT and Allergy Associates Continues to Bolster Bayside Presence and Expertise, Adds Allergist/Immunologist Dr. Brian Safier
5. Studies confirm presence, severity of pollution in national parks
6. Certain cancer therapies success depends on presence of immune cell, Stanford study shows in mice
7. Poor breast cancer prognosis associated with presence of circulating tumor, cancer stem cells
8. Third trimester group B streptococcus test doesnt accurately predict presence during labor
9. Ultrasensitive detector pinpoints big problem in tiny fetal heart
10. Fetal alcohol spectrum disorder linked to high prevalence of epilepsy, Queens study
11. Study finds changes in fetal epigenetics throughout pregnancy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... 2016 , ... "I had a terrible time trying to get my grandson ... if the nebulizer had a more child-friendly design, then children would be more likely ... patent-pending NEBY to avoid the need to deliver medication via a nebulizer mask. The ...
(Date:12/8/2016)... ... December 08, 2016 , ... The West Virginia Medical ... 2017. The name change aligns the entire company with its existing Quality ... quality. , “We are very proud of the achievements associated with the West ...
(Date:12/8/2016)... ... 2016 , ... After enjoying record-breaking attendance at its last ... 33rd Annual Issues & Research Conference, March 2-3, 2017, at the Westin ... is “Persistent Challenges and New Opportunities: Using Research to Accelerate the Dialogue." 2016 ...
(Date:12/8/2016)... NY (PRWEB) , ... December 08, 2016 , ... ... is pleased to announce that “Natural Language Processing–Enabled and Conventional Data Capture Methods ... in JMIR Medical Informatics . , Results of the comparative usability study ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... Medication Therapy Management (MTM), adherence, and other pharmacist-delivered patient care services, has announced ... counsel and Eric Hoessel to vice president of sales. , Litsinger joined ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Allergy Diagnostics Market: Scope and Methodology ... are used to determine the presence of allergens ... etc. in the samples by determining the presence ... report on global allergy diagnostics market, analyzes the ... report consists of an executive summary that provides ...
(Date:12/8/2016)... Research and Markets has announced the addition of the "Global ... - Forecast to 2025" report to their offering. ... , , ... a CAGR of around 3.2% from 2015 to 2025. Some of ... extracellular microelectrode arrays and intracellular microelectrodes, research in left-to-right shunt detection ...
(Date:12/8/2016)... CITY , Dec. 8, 2016 ... US patents for improving the accuracy, reproducibility and ... images in long and small bone orthopaedic applications. ... approach to creating personalized orthopaedic restorations based on ... personalized orthopaedic restorations, the company harnesses the world,s ...
Breaking Medicine Technology: